META-INSTI: metabolic adverse events following integrase strand transfer inhibitor administration in spontaneous adverse event reports
Background: Metabolic effects of integrase strand transfer inhibitors (INSTIs) have been reported. The FDA Adverse Event Reporting System (FAERS) is a publicly available database that captures spontaneously reported adverse events. The objective of this study was to evaluate the relationship between...
Main Authors: | Milena M Murray, Lara Fakhouri, Spencer E Harpe |
---|---|
Format: | Article |
Language: | English |
Published: |
BioExcel Publishing Ltd
2023-08-01
|
Series: | Drugs in Context |
Subjects: | |
Online Access: | https://www.drugsincontext.com/meta-insti-metabolic-adverse-events-following-integrase-strand-transfer-inhibitor-administration-in-spontaneous-adverse-event-reports/ |
Similar Items
-
A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection
by: Alexa Vyain Zhao, et al.
Published: (2022-10-01) -
HIV drug resistance against strand transfer integrase inhibitors
by: Kaitlin Anstett, et al.
Published: (2017-06-01) -
Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs
by: Steven J. Smith, et al.
Published: (2021-01-01) -
Genetic Features of HIV-1 Integrase Sub-Subtype A6 Predominant in Russia and Predicted Susceptibility to INSTIs
by: Alina Kirichenko, et al.
Published: (2020-07-01) -
The effect of a treatment switch to integrase Strand transfer inhibitor–based regimens on weight gain and other metabolic syndrome-related conditions
by: Omer Maman, et al.
Published: (2024-02-01)